Skip to Main Content

Author Details

Subha Madhavan
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
2009
89
28
PMIDPaper TitleJournal TitlePublished Year
36373660CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.Nucleic Acids Res2023
36373660CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.Nucleic Acids Res2023
36780362Patient-Reported Data Augment Prediction Models of Persistent Opioid Use after Elective Upper Extremity Surgery.Plast Reconstr Surg2023
36951119The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.Cancer2023
36702828Author Correction: Federated learning enables big data for rare cancer boundary detection.Nat Commun2023
36951119The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.Cancer2023
36780362Patient-Reported Data Augment Prediction Models of Persistent Opioid Use after Elective Upper Extremity Surgery.Plast Reconstr Surg2023
36702828Author Correction: Federated learning enables big data for rare cancer boundary detection.Nat Commun2023
35101336Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
35701399Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features.Sci Data2022
35832288Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer Survival.Cancer Res Commun2022
36274654Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation.Front Digit Health2022
35624339A community approach to the cancer-variant-interpretation bottleneck.Nat Cancer2022
35366592Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions.Cancer Genet2022
36139703Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. <i>Cancers</i> 2021, <i>13</i>, 6109.Cancers (Basel)2022
35798754Author Correction: Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features.Sci Data2022
35485600A research agenda to support the development and implementation of genomics-based clinical informatics tools and resources.J Am Med Inform Assoc2022
36063163Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
35402858Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.NAM Perspect2022
36470898Federated learning enables big data for rare cancer boundary detection.Nat Commun2022
35101336Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
35798754Author Correction: Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features.Sci Data2022
35402858Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.NAM Perspect2022
35701399Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features.Sci Data2022
35832288Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer Survival.Cancer Res Commun2022
35366592Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions.Cancer Genet2022
35624339A community approach to the cancer-variant-interpretation bottleneck.Nat Cancer2022
35485600A research agenda to support the development and implementation of genomics-based clinical informatics tools and resources.J Am Med Inform Assoc2022
36470898Federated learning enables big data for rare cancer boundary detection.Nat Commun2022
36274654Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation.Front Digit Health2022
36139703Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. <i>Cancers</i> 2021, <i>13</i>, 6109.Cancers (Basel)2022
36063163Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
33260207Use of electronic health records to support a public health response to the COVID-19 pandemic in the United States: a perspective from 15 academic medical centers.J Am Med Inform Assoc2021
33613843High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma.Oncotarget2021
33989017Automated Identification of Patients With Immune-Related Adverse Events From Clinical Notes Using Word Embedding and Machine Learning.JCO Clin Cancer Inform2021
33447854Recommendations for the safe, effective use of adaptive CDS in the US healthcare system: an AMIA position paper.J Am Med Inform Assoc2021
33260207Use of electronic health records to support a public health response to the COVID-19 pandemic in the United States: a perspective from 15 academic medical centers.J Am Med Inform Assoc2021
35121893Envisioning the future of precision oncology trials.Nat Cancer2021
33613843High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma.Oncotarget2021
35121893Envisioning the future of precision oncology trials.Nat Cancer2021
33989017Automated Identification of Patients With Immune-Related Adverse Events From Clinical Notes Using Word Embedding and Machine Learning.JCO Clin Cancer Inform2021
33447854Recommendations for the safe, effective use of adaptive CDS in the US healthcare system: an AMIA position paper.J Am Med Inform Assoc2021
32561076A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience.Surg Oncol2020
32135080Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.Lancet Oncol2020
32246132A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.Nat Genet2020
31990579Evidence-Based Network Approach to Recommending Targeted Cancer Therapies.JCO Clin Cancer Inform2020
32594908Allele-specific DNA methylation is increased in cancers and its dense mapping in normal plus neoplastic cells increases the yield of disease-associated regulatory SNPs.Genome Biol2020
32644817Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices.JCO Clin Cancer Inform2020
32561076A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience.Surg Oncol2020
32781193De novo assembly and annotation of transcriptomes from two cultivars of Cannabis sativa with different cannabinoid profiles.Gene2020
  • 1 - 50 of 178

Recommended Authors

Career Start Year 2017
Number of shared co-authors 7
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 7
The Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 2
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 2012
Number of shared co-authors 8
Immuneering Corporation
Career Start Year 2012
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 3
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 1
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 4
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 2
Brigham Young University
Career Start Year 2008
Number of shared co-authors 3
T.J. Watson Research Center
Career Start Year 2008
Number of shared co-authors 0
Northwestern University
Career Start Year 2008
Number of shared co-authors 5
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 2
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 3
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 1
University of Washington
Career Start Year 2006
Number of shared co-authors 16
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 6
University of Chicago
Career Start Year 2003
Number of shared co-authors 18
University of California
Career Start Year 2003
Number of shared co-authors 1
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 2
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 2
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 8
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 7
University of Chicago
Career Start Year 1998
Number of shared co-authors 7
University of California los angeles
Career Start Year 1991
Number of shared co-authors 7
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 6
Duke Clinical Research Institute, Duke University
Career Start Year 1987
Number of shared co-authors 12
Center for Biomedical Informatics and Biostatistics, University of Arizona
Career Start Year 1971
Number of shared co-authors 10

Collaborators

Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Co-authored papers 25
Georgetown University Medical Center
Co-authored papers 15
Baylor College of Medicine
Co-authored papers 12
Washington University
Co-authored papers 11
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 11
Washington University
Co-authored papers 11
Co-authored papers 11
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 10
National Cancer Institute
Co-authored papers 8
Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis
Co-authored papers 8
Children's Hospital Los Angeles
Co-authored papers 8
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 7
Centene Center for Health Transformation, Centene Corporation
Co-authored papers 7
Washington University School of Medicine
Co-authored papers 7
University of Virginia
Co-authored papers 6
German Cancer Consortium and German Cancer Research Center
Co-authored papers 5
Texas Children's Hospital and Baylor College of Medicine
Co-authored papers 5
Mayo Clinic
Co-authored papers 4
Washington University
Co-authored papers 4
Washington University
Co-authored papers 4
Washington University
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Co-authored papers 4
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 4
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
University of Pennsylvania
Co-authored papers 4
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 4